Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 8/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.50 |
| ▸ | NOS2 | P35228 | 8/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14415641 | 0.78 | SLC6A4 (0.57) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL14415642 | 0.76 | SLC6A4 (0.58) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL7306575 | 0.74 | HTR6 (0.54) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL19668669 | 0.73 | SLC6A2 (0.55) | SLC6A2SLC6A4NOS2CYP2D6 | |
| SCHEMBL7050753 | 0.72 | SLC6A4 (0.68) | SLC6A2SLC6A4NOS2CYP2D6IDO1 | |
| SCHEMBL27769297 | 0.72 | AOC3 (0.45) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL14415643 | 0.71 | SLC6A4 (0.52) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL14415625 | 0.71 | SLC6A2 (0.50) | SLC6A2SLC6A4NOS2CYP2D6AOC3 | |
| SCHEMBL18096541 | 0.71 | SLC6A2 (0.56) | SLC6A2SLC6A4AOC3HTR6 | |
| SCHEMBL5310035 | 0.71 | SLC6A4 (0.49) | SLC6A2SLC6A4CYP2D6ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005079284-A2 | METHODS AND REAGENTS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED LEVELS OF PROINFLAMMATORY CYTOKINES | COMBINATORX, INCORPORATED (US) | 2005-09-01 | — | — | WO | disclosed |